Abbott India, incorporated in the year 1944, is a Large Cap company (having a market cap of Rs 49810.49 Crore) operating in Pharmaceuticals sector.
Abbott India key Products/Revenue Segments include Injectables, Tablets, Liquids, Capsules, Service Income, Others, Ointments, Granules, Powder, Other Operating Revenue, Export Incentives, Scrap for the year ending 31-Mar-2022.
Financials
For the quarter ended 31-03-2023, the company has reported a Standalone Total Income of Rs 1392.72 Crore, up 1.92 % from last quarter Total Income of Rs 1366.42 Crore and up 9.14 % from last year same quarter Total Income of Rs 1276.07 Crore. Company has reported net profit after tax of Rs 231.42 Crore in latest quarter.
Investment Rationale
The brokerage sees Abbott and Ajanta to likely grow organically at a faster pace of 15-16%
Promoter/FII Holdings
Promoters held 74.99 per cent stake in the company as of March 2023 quarter, while FIIs owned 0.19% stake and DIIs 8.59 per cent.
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Top Trending Stocks: SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price